Web Results

Earnings Roundup: What You Need to Know About Gilead's ...

www.fool.com/investing/general/2014/04/23/earnings-roundup-what-you-need-to-know-about-gilea.aspx

Apr 23, 2014 ... Gilead (GILD) posted blockbuster sales for Sovaldi, outpacing ... Earnings Roundup: What You Need to Know About Gilead's Blockbuster Quarter. Gilead ... Olysio's sales totaled $350 million in the first quarter as the drug was ...

What's in Store for Gilead (GILD) this Earnings Season? - October ...

www.zacks.com/stock/news/194867/whats-in-store-for-gilead-gild-this-earnings-season

Oct 23, 2015 ... Gilead's earnings track record has been pretty good – last quarter, the company ... Gilead's blockbuster hepatitis C virus (HCV) treatments, Sovaldi and Harvoni, are ... Harvoni should benefit from reimbursement in several European countries. ... Today, you can download 7 Best Stocks for the Next 30 Days.

Gilead 1Q profit tumbles on slower hepatitis C drug sales

www.redding.com/news/377489971.xhtml

By using this site, you agree to the Privacy Policy and Terms of Use. .... WASHINGTON (AP) - Gilead Science Inc.'s earnings tumbled more than 17 percent in the first quarter as steeper discounts and rebates on its blockbuster hepatitis C drugs cut ... "This was a weak quarter for Gilead, in our view, as sales for hepatitis C ...

The Zacks Analyst Blog Highlights: Biogen, Sarepta, Catalyst ...

finance.yahoo.com/news/zacks-analyst-blog-highlights-biogen-133001249.html

3 days ago ... Quotes you view appear here for quick access. ... The Zacks Analyst Blog Highlights: Biogen, Sarepta, Catalyst Pharmaceuticals, AbbVie and Gilead ... Biotech Stock Roundup. Biogen (BIIB) kick-started the earnings season for the biotech sector ... Biogen's first-quarter results were mixed with the company ...

Morning Briefings | Kaiser Health News

khn.org/Daily-Report.aspx

If you have a health policy haiku to share, please Contact Us and let us know if you ... they would be eligible for Medicaid should soon have access to health care, .... Aetna's first-quarter earnings slid nearly 7 percent as enrollment dipped, but ... The drugmaker Gilead Sciences has seen its fortunes buoyed by its blockbuster ...

Drug Channels: October 2014

www.drugchannels.net/2014_10_01_archive.html

Oct 1, 2014 ... News Roundup, October 2014: Walgreens, Cardinal Health, ... Yesterday, Gilead Sciences reported another blockbuster quarter for Sovaldi sales. ... Based on the chart below, I think you'll agree that Sovaldi is the most legendary of them all. ... should—but probably won't—mute critics of preferred networks.

European Regulatory Roundup: Germany Joins EU Medical ... - RAPS

www.raps.org/Regulatory-Focus/News/2016/04/21/24806/European-Regulatory-Roundup-Germany-Joins-EU-Medical-Countermeasure-Procurement-Alliance-21-April-2016/

Apr 21, 2016 ... Welcome to our European Regulatory Roundup, our weekly ... If successful, the trial could lead to PRAC running its first public hearing in the fourth quarter of 2016. ... hepatitis C drugs including Gilead Sciences' Sovaldi and Harvoni. ... is required to run high-quality clinical trials in pediatric populations.

Earnings Roundup: Embattled Valeant Pharmaceuticals Intl Inc ...

www.smarteranalyst.com/2016/03/18/earnings-roundup-embattled-valeant-pharmaceuticals-intl-inc-nysevrx-and-mannkind-corporation-nasdaqmnkd-struggle-to-regain-public-favor/

Mar 18, 2016 ... MannKind reported fourth quarter earnings on Tuesday. ... hopes pinned on Afrezza becoming the next blockbuster drug as the first inhable insulin for adults with diabetes, but the drug failed to bring in meaningful revenue and gain traction ... Biotech Beat: Analysts Weigh In On Gilead Sciences, Inc. (GILD), ...

What you need to know for the Rascal Flatts concert - Press of ...

www.pressofatlanticcity.com/life/what-you-need-to-know-for-the-rascal-flatts-concert/article_32bcdc2a-45f6-11e5-b6cd-8bde44f946e6.html

Aug 19, 2015 ... Wear comfortable shoes, because it's a lot easier to stand and listen to the concert — and sit in the sand, if you need to — than it is to drag ...

Business & economy news, features & trends - News, Weather and ...

www.klkntv.com/category/89521/business

According to a new patent, It has a tiny display and a camera that you can control by blinking your eye ..... Electric car buying guide: Everything you need to know.

More Info

Can Gilead (GILD) Keep the Earnings Streak Alive in Q4? - January ...

www.zacks.com

Jan 29, 2016 ... Gilead Sciences Inc. (GILD) is scheduled to report fourth-quarter ... Gilead's blockbuster hepatitis C virus (HCV) treatments are ... Conversely, Sell-rated stocks (#4 or 5) should never be considered going into an earnings announcement, ... Apart from Gilead, here are a few health care stocks that you may ...

Business News Roundup, April 29 - SFGate

www.sfgate.com

3 days ago ... Gilead Science Inc.'s earnings tumbled 17 percent in the first quarter as sales of its blockbuster hepatitis C drug slowed faster than ... Amazon.com Inc. on Thursday reported first-quarter net income of $513 million, after ... and other executives had urged him to bring new blood into the company's leadership.

Biotech Stock Roundup: Biogen Tops on Q1 Earnings, Sarepta ...

finance.yahoo.com

4 days ago ... Quotes you view appear here for quick access. ... Biogen BIIB kick-started the earnings season for the biotech sector with ... Biogen's first-quarter results were mixed with the company ... Gilead GILD gained EU approval for two doses of its HIV treatment, .... Did You Know Every New Car Has a Secret Price?